Lokesh Maru - Nippon Life Research Associate
| NAM-INDIA | 679.20 4.25 0.63% |
Executive
Lokesh Maru is Research Associate of Nippon Life India
| Address | Tower A, 4th Floor, Mumbai, India, 400 013 |
| Phone | 022 5663 4800 |
| Web | https://www.nipponindiamf.com/AboutUs/CompanyProfi |
Nippon Life Management Efficiency
The company has return on total asset (ROA) of 0.2458 % which means that it generated a profit of $0.2458 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3457 %, meaning that it generated $0.3457 on every $100 dollars invested by stockholders. Nippon Life's management efficiency ratios could be used to measure how well Nippon Life manages its routine affairs as well as how well it operates its assets and liabilities. At present, Nippon Life's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 32.2 B, whereas Non Current Assets Total are forecasted to decline to about 4.5 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rajesh Chawla | Varun Beverages Limited | N/A | |
| Ronica Baruah | Metropolis Healthcare Limited | N/A | |
| Deepak Sharma | Varun Beverages Limited | 51 | |
| Jatin Singhal | The Byke Hospitality | N/A | |
| Ishita Medhekar | Metropolis Healthcare Limited | N/A | |
| Manoj Srivastava | Medplus Health Services | N/A | |
| Kannan Alangadan | Metropolis Healthcare Limited | N/A | |
| Kirti Chadha | Metropolis Healthcare Limited | N/A | |
| Radheshyam Maharana | The Byke Hospitality | N/A | |
| Rohit Gupta | Varun Beverages Limited | N/A | |
| Jeyasingh Balakrishnan | Metropolis Healthcare Limited | N/A | |
| Ravi Batra | Varun Beverages Limited | 52 | |
| Pradeep Mahindrakar | Metropolis Healthcare Limited | N/A | |
| Abdur Razzaque | Metropolis Healthcare Limited | N/A | |
| Rajeshwar Tripathi | Varun Beverages Limited | N/A | |
| Bhaskar Cherukupalli | Medplus Health Services | N/A | |
| Puneet Nigam | Metropolis Healthcare Limited | N/A | |
| Chetan Dikshit | Medplus Health Services | N/A | |
| Surendranath Mantena | Medplus Health Services | N/A | |
| Kandasamy Vairaperumal | Medplus Health Services | N/A | |
| Pinakin Shah | Metropolis Healthcare Limited | N/A | |
Management Performance
| Return On Equity | 0.35 | ||||
| Return On Asset | 0.25 |
Nippon Life India Leadership Team
Elected by the shareholders, the Nippon Life's board of directors comprises two types of representatives: Nippon Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nippon. The board's role is to monitor Nippon Life's management team and ensure that shareholders' interests are well served. Nippon Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nippon Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sailesh CFA, Chief Investments | ||
| Ashish Chugani, Head Assets | ||
| Dhrumil Shah, CoFund Investments | ||
| Amber Singhania, Research Equity | ||
| Valde Varghese, Company Secretary | ||
| Amiyesh Verma, Head Strategy | ||
| Sunil CFA, Chief Investments | ||
| Saugata Chatterjee, Chief Distribution | ||
| Parag Joglekar, Chief Officer | ||
| Prateek Jain, Chief Officer | ||
| Abhijit Shah, Chief Officer | ||
| Sandeep Walunj, Chief Officer | ||
| Aishwarya Agarwal, Fund Analyst | ||
| Sanjiv Gudal, Head Group | ||
| Rajesh Jayaraman, Head Product | ||
| Muneesh Sud, Chief Officer | ||
| Rajesh Derhgawen, Chief Officer | ||
| Milind Nesarikar, Chief Service | ||
| Nilufer Shekhawat, Company Officer | ||
| Amol Bilagi, Interim Accounts | ||
| Sundeep MBA, CEO Director | ||
| Amit Tripathi, Chief Investments | ||
| Pradeep Andrade, Head Administration | ||
| Arash Arethna, Lead Relations | ||
| Abhijit Singh, CEO Singapore | ||
| Kaiyomurz Daver, Chief Officer | ||
| Lokesh Maru, Research Associate |
Nippon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nippon Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.35 | ||||
| Return On Asset | 0.25 | ||||
| Profit Margin | 0.55 % | ||||
| Operating Margin | 0.70 % | ||||
| Current Valuation | 421.05 B | ||||
| Shares Outstanding | 633.33 M | ||||
| Shares Owned By Insiders | 0.55 % | ||||
| Shares Owned By Institutions | 89.14 % | ||||
| Price To Book | 10.58 X | ||||
| Price To Sales | 18.34 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nippon Stock
Nippon Life financial ratios help investors to determine whether Nippon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nippon with respect to the benefits of owning Nippon Life security.